This educational activity is specifically designed for psychiatrists, psychologists and other physicians, clinicians, physicians-in-training, and healthcare professionals (psychiatry nurses, pharmacists, physician assistants) involved and/or interested in the therapeutic management of patients with psychotic and mood disorders. Objectives After successful completion of this educational activity, attendees should be able to:
Review the efficacy and safety of antipsychotic agents in the treatment of schizophrenia
Discuss the side effects associated with first and second generation antipsychotics
Comment on the role of polypharmacy in schizophrenia
Outline a therapeutic strategy to overcome refractory psychosis
Discuss diagnostic and treatment strategies for major depression with psychotic features
Summarize available and emerging treatment options for dementia with psychotic features
Discuss the nonpharmacological options for patients (such as exercise and neuromodulation) with depressive disorders
Expand the therapeutic armamentarium for comorbid depression and anxiety
Describe the therapeutic strategies available to treat bipolar depression in adults and in children
Summarize the effective management of patients who experience mixed episodes
Discuss pathophysiology of fibromyalgia and the mechanisms of agents used to treat patients with this disorder
Past Events
Clinical Dialogue: Update on Psychopharmacology - 30 Apr - 01 May, 2010, Sheraton New York Times Square Hotel, New York City, New York, United States (2688)
Clinical Dialogue: Update on Psychopharmacology 2026
Important
Please, check "Clinical Dialogue: Update on Psychopharmacology" official website for possible changes, before making any traveling arrangements
